Stock Market News1 month AbbVie’s Recently Acquired Parkinson’s Drug Meets Third Study Goal Zacks
Data from a late-stage study shows that treatment with flexible doses of ABBV’s tavapadon reduced the burden of Parkinson’s disease.
XData from a late-stage study shows that treatment with flexible doses of ABBV’s tavapadon reduced the burden of Parkinson’s disease.
X